Eaton Vance Management raised its stake in Dentsply International Inc. (NASDAQ:XRAY) by 0.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,414 shares of the company’s stock after buying an additional 19 shares during the period. Eaton Vance Management’s holdings in Dentsply International were worth $2,507,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of XRAY. Checchi Capital Advisers LLC boosted its stake in shares of Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock worth $125,000 after buying an additional 41 shares during the last quarter. Global X Management Co. LLC boosted its stake in shares of Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock worth $197,000 after buying an additional 1,661 shares during the last quarter. Evercore Wealth Management LLC boosted its stake in shares of Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock worth $199,000 after buying an additional 358 shares during the last quarter. Carnick & Kubik LLC purchased a new stake in shares of Dentsply International during the first quarter worth approximately $201,000. Finally, Cacti Asset Management LLC purchased a new stake in shares of Dentsply International during the second quarter worth approximately $203,000. Institutional investors own 94.58% of the company’s stock.

Shares of Dentsply International Inc. (NASDAQ:XRAY) traded down 0.643% on Thursday, reaching $59.505. The company’s stock had a trading volume of 1,181,681 shares. The company has a 50 day moving average of $60.83 and a 200 day moving average of $61.57. Dentsply International Inc. has a 1-year low of $49.48 and a 1-year high of $65.83. The stock has a market capitalization of $13.87 billion, a P/E ratio of 27.924 and a beta of 1.40.

Dentsply International (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.06. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company posted $0.73 earnings per share. Dentsply International’s quarterly revenue was up 46.4% on a year-over-year basis. Equities research analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.

A number of equities research analysts have recently commented on XRAY shares. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Dentsply International in a research note on Sunday, June 5th. Piper Jaffray Cos. reiterated a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Bank of America Corp. started coverage on Dentsply International in a research report on Monday, September 12th. They set a “buy” rating and a $70.00 target price on the stock. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Finally, Zacks Investment Research lowered Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $67.00.

In related news, SVP Maureen J. Macinnis sold 45,100 shares of the company’s stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the transaction, the senior vice president now owns 36,730 shares of the company’s stock, valued at $2,224,001.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rainer Berthan sold 5,000 shares of the company’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total value of $305,600.00. Following the transaction, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.